Search
Search Results
##search.searchResults.foundPlural##
-
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3744Suppl. Files: 1046PDF: 1020Html: 107 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4706PDF: 1707HTML: 2686Untitled: 190 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1244PDF: 981HTML: 108 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1503PDF: 856HTML: 964figures: 153table 1: 163table2: 161table3: 162 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4150PDF: 1132HTML: 2119Figure 1: 147 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1691PDF: 501HTML: 16957Figure 4: 144Figure 3: 125Figure 2: 124Figure 1: 154 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1856PDF: 1124HTML: 248 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1484PDF: 824HTML: 1022Picture 1: 151 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3767PDF: 1410HTML: 8486 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1083PDF: 875HTML: 280 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1336PDF: 796HTML: 3103 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1321PDF: 1270HTML: 79 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3666PDF: 1415HTML: 459Figures . Eliassian: 203 -
Stroke in a patient with tuberculous meningitis and HIV infection
1535PDF: 771HTML: 1707figure 1: 137 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
682PDF: 474Suppl. Files: 107HTML: 76 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1113PDF: 801HTML: 2164Figue 1: 158 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1726PDF: 1019HTML: 214 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1755PDF: 805HTML: 1548 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2433PDF: 817HTML: 8787Efremov 1: 205Efremov 2: 165 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
1947PDF: 1823HTML: 327 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2972PDF: 835HTML: 7149Kost Fig1: 164Kost Fig 2: 155Kost Fig3: 151Kost Fig 4: 169Kost Fig5: 164Kost fig 6: 151 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1523PDF: 848HTML: 3144Figure 5: 145Figure 4: 144Figure 3: 175Figure 1: 157Figure 2: 148 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3995PDF: 1534HTML: 834 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4241PDF: 1448HTML: 1531Untitled: 210







